Drawing for SPAN

USPTO serial 97608515

SPAN

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
WANG, ASHLEY
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with SPAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $896*

Plus Government fees of $500

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anuj Desai

Anuj Desai ARNALL GOLDEN GREGORY LLP171 17TH ST NWSUITE 2100ATLANTA, GA 30363

Goods and services

ClassDescriptionStatusFirst use
009Recorded computer programs for integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems to support and interface with cloud-based software as a service (SAAS) services; Recorded medical software for integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems to support and interface with cloud-based software as a service (SAAS) servicesACTIVE—
035Business consultation in the field of health and individual patient risk assessments, use of adaptive nudges in clinical decision points, outcomes-based health care, prediction of health outcomes, improvement of health outcomes, artificial intelligence-enabled decision support technology, prescriptive analytics, patient data analytics, integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems for identifying risks and improving outcomes at point of care, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Business consulting services in the field of health and individual patient risk assessments, use of adaptive nudges in clinical decision points, outcomes-based health care, prediction of health outcomes, improvement of health outcomes, artificial intelligence-enabled decision support technology, prescriptive analytics, patient data analytics, integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems for identifying risks and improving outcomes at point of care, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Business assistance, advisory and consulting services in the field of health and individual patient risk assessments, use of adaptive nudges in clinical decision points, outcomes-based health care, prediction of health outcomes, improvement of health outcomes, artificial intelligence-enabled decision support technology, prescriptive analytics, patient data analytics, integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems for identifying risks and improving outcomes at point of care, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Consulting services in the cost management of health careACTIVE—
042Application service provider (ASP) featuring software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing a website featuring non-downloadable software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing on-line non-downloadable software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Software as a service (SAAS) services, namely, hosting software for use by others for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Software as a service (SAAS) services featuring software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse eventsACTIVE—
044Consulting services in the field of medical care; Health care consulting in the field of health and individual patient risk assessments, use of adaptive nudges in clinical decision points, outcomes-based health care, prediction of health outcomes, improvement of health outcomes, artificial intelligence-enabled decision support technology, prescriptive analytics, patient data analytics, integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems for identifying risks and improving outcomes at point of care, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Consulting services in the field of healthcare; Providing health care information by providing a website, use of online non-downloadable software, or via digital publications and videos; Providing health care information via a global computer network; Providing healthcare informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 13, 2026EX5GSOU EXTENSION 5 GRANTED—
Apr 10, 2026EXT5SOU EXTENSION 5 FILED—
Apr 10, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2025EX4GSOU EXTENSION 4 GRANTED—
Oct 10, 2025EXT4SOU EXTENSION 4 FILED—
Oct 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2025EX3GSOU EXTENSION 3 GRANTED—
Apr 10, 2025EXT3SOU EXTENSION 3 FILED—
Apr 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 10, 2024EXT2SOU EXTENSION 2 FILED—
Oct 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 10, 2024EXT1SOU EXTENSION 1 FILED—
Apr 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2023DOCKASSIGNED TO EXAMINER—
Oct 14, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 30, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance